|
US5137877B1
(en)
|
1990-05-14 |
1996-01-30 |
Bristol Myers Squibb Co |
Bifunctional linking compounds conjugates and methods for their production
|
|
US6569834B1
(en)
|
1992-12-03 |
2003-05-27 |
George R. Pettit |
Elucidation and synthesis of antineoplastic tetrapeptide w-aminoalkyl-amides
|
|
US5635483A
(en)
|
1992-12-03 |
1997-06-03 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Tumor inhibiting tetrapeptide bearing modified phenethyl amides
|
|
PL178766B1
(pl)
|
1992-12-16 |
2000-06-30 |
Basf Ag |
Nowe peptydy
|
|
US5780588A
(en)
|
1993-01-26 |
1998-07-14 |
Arizona Board Of Regents |
Elucidation and synthesis of selected pentapeptides
|
|
EP0731106B1
(en)
|
1993-10-01 |
2004-11-17 |
Teikoku Hormone Mfg. Co., Ltd. |
Dolastatin derivatives
|
|
US5599902A
(en)
|
1994-11-10 |
1997-02-04 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Cancer inhibitory peptides
|
|
US5663149A
(en)
|
1994-12-13 |
1997-09-02 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides
|
|
GB9508195D0
(en)
|
1995-04-20 |
1995-06-07 |
Univ British Columbia |
Novel biologically active compounds and compositions,their use and derivation
|
|
CA2225325A1
(en)
*
|
1997-12-19 |
1999-06-19 |
The University Of British Columbia |
Hemiasterlin analogs
|
|
US8097648B2
(en)
|
1998-06-17 |
2012-01-17 |
Eisai R&D Management Co., Ltd. |
Methods and compositions for use in treating cancer
|
|
US6323315B1
(en)
|
1999-09-10 |
2001-11-27 |
Basf Aktiengesellschaft |
Dolastatin peptides
|
|
US7256257B2
(en)
|
2001-04-30 |
2007-08-14 |
Seattle Genetics, Inc. |
Pentapeptide compounds and uses related thereto
|
|
US6884869B2
(en)
|
2001-04-30 |
2005-04-26 |
Seattle Genetics, Inc. |
Pentapeptide compounds and uses related thereto
|
|
EP1531846A4
(en)
|
2002-02-27 |
2006-04-19 |
Us Gov Health & Human Serv |
Conjugates of ligand, linker and cytotoxic agent and related compositions and methods of use
|
|
US7064211B2
(en)
|
2002-03-22 |
2006-06-20 |
Eisai Co., Ltd. |
Hemiasterlin derivatives and uses thereof
|
|
KR101208266B1
(ko)
*
|
2002-03-22 |
2012-12-05 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
헤미아스텔린 유도체 및 이의 용도
|
|
WO2003090678A2
(en)
|
2002-04-23 |
2003-11-06 |
Ohio State University |
Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin
|
|
ITMI20021391A1
(it)
|
2002-06-25 |
2003-12-29 |
Nicox Sa |
Nitroderivati di inibitori della cicloossigenasi-2
|
|
DK1545613T3
(da)
|
2002-07-31 |
2011-11-14 |
Seattle Genetics Inc |
Auristatinkonjugater og deres anvendelse til behandling af cancer, en autoimmun sygdom eller en infektiøs sygdom
|
|
MXPA05002874A
(es)
|
2002-09-20 |
2005-05-27 |
Wyeth Corp |
Procedimiento para la sintesis de intermediarios utiles para la sintesis de inhibidores de tubulina.
|
|
WO2004026293A2
(en)
*
|
2002-09-20 |
2004-04-01 |
Wyeth Holdings Corporation |
Hemiasterlin derivatives for treating resistant tumors
|
|
AU2003295808A1
(en)
|
2002-11-21 |
2004-06-18 |
Wyeth |
Hemiasterlin affinity probes and their uses
|
|
US7390910B2
(en)
|
2003-08-08 |
2008-06-24 |
Wyeth |
Compounds for treating tumors
|
|
US7576206B2
(en)
|
2003-08-14 |
2009-08-18 |
Cephalon, Inc. |
Proteasome inhibitors and methods of using the same
|
|
CA2538829A1
(en)
|
2003-09-15 |
2005-03-24 |
The University Of British Columbia |
Ceratamines a and b, and analogues, syntheses and pharmaceutical compositions thereof
|
|
EP1675465B1
(en)
|
2003-10-22 |
2010-03-03 |
The Johns Hopkins University |
Improved combination bacteriolytic therapy for the treatment of tumors
|
|
EP2478912B1
(en)
|
2003-11-06 |
2016-08-31 |
Seattle Genetics, Inc. |
Auristatin conjugates with anti-HER2 or anti-CD22 antibodies and their use in therapy
|
|
US7078562B2
(en)
|
2004-01-19 |
2006-07-18 |
Mitsubishi Gas Chemical Company, Inc. |
Adamantane derivatives and resin compositions using the same as raw material
|
|
KR20070053214A
(ko)
*
|
2004-08-26 |
2007-05-23 |
니콜라스 피라말 인디아 리미티드 |
신규 생분해성 링커를 함유하는 프로드럭
|
|
US20090130136A1
(en)
*
|
2004-09-30 |
2009-05-21 |
Miller Louis H |
Chondroitin Sulphate a Binding Domains
|
|
US8288352B2
(en)
|
2004-11-12 |
2012-10-16 |
Seattle Genetics, Inc. |
Auristatins having an aminobenzoic acid unit at the N terminus
|
|
JP2008521828A
(ja)
|
2004-11-29 |
2008-06-26 |
シアトル ジェネティックス， インコーポレイテッド |
操作された抗体およびイムノコンジュゲート
|
|
ES2708763T3
(es)
|
2005-07-07 |
2019-04-11 |
Seattle Genetics Inc |
Compuestos de monometilvalina que tienen modificaciones de la cadena lateral de fenilalanina en el extremo C
|
|
WO2007008848A2
(en)
|
2005-07-07 |
2007-01-18 |
Seattle Genetics, Inc. |
Monomethylvaline compounds having phenylalanine carboxy modifications at the c-terminus
|
|
AR068756A1
(es)
|
2007-10-10 |
2009-12-02 |
Novartis Ag |
Compuestos peptidicos, formulacion farmaceutica y sus usos como moduladores del virus de la hepatitis c
|
|
US20090155289A1
(en)
|
2007-11-01 |
2009-06-18 |
Steve Roberts |
Furin-cleavable peptide linkers for drug-ligand conjugates
|
|
CN101932598B
(zh)
|
2008-01-30 |
2016-12-21 |
皮里斯股份公司 |
具有对人c-met受体酪氨酸激酶的亲和性的泪脂质运载蛋白的突变蛋白及其获得方法
|
|
DK2265283T3
(da)
|
2008-03-18 |
2014-10-20 |
Seattle Genetics Inc |
Auristatin-lægemiddel-linker-konjugater
|
|
EP3552622A3
(en)
*
|
2008-11-21 |
2019-12-04 |
Københavns Universitet (University Of Copenhagen) |
Priming of an immune response
|
|
US20110182850A1
(en)
|
2009-04-10 |
2011-07-28 |
Trixi Brandl |
Organic compounds and their uses
|
|
US8394922B2
(en)
|
2009-08-03 |
2013-03-12 |
Medarex, Inc. |
Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
|
|
KR101678255B1
(ko)
|
2009-09-25 |
2016-11-21 |
아스텔라스세이야쿠 가부시키가이샤 |
치환 아미드 화합물
|
|
WO2011154359A1
(de)
|
2010-06-10 |
2011-12-15 |
Bayer Pharma Aktiengesellschaft |
Neue auristatin-derivate und ihre verwendung
|
|
FR2963241B1
(fr)
*
|
2010-07-30 |
2014-10-24 |
Inst Rech Developpement Ird |
Vaccin contre le paludisme gestationnel
|
|
PH12012500542A1
(en)
|
2010-09-24 |
2012-11-12 |
Astellas Pharma Inc |
Substituted amide compound
|
|
WO2012113847A1
(en)
|
2011-02-25 |
2012-08-30 |
Lonza Ltd |
Branched linker for protein drug conjugates
|
|
US9200034B2
(en)
|
2011-03-16 |
2015-12-01 |
Council Of Scientific & Industrial Research |
Oligopeptides and process for preparation thereof
|
|
AU2012236511B2
(en)
|
2011-03-30 |
2016-04-28 |
Arizona Board Of Regents, For And On Behalf Of, Arizona State University |
Auristatin tyramine phosphate salts and auristatin aminoquinoline derivatives and prodrugs thereof
|
|
BR112013027119A8
(pt)
|
2011-04-21 |
2018-03-06 |
Seattle Genetics Inc |
novos conjugados ligante-droga (adcs) e uso dos mesmos
|
|
US20130190248A1
(en)
|
2011-07-26 |
2013-07-25 |
Agensys, Inc. |
Substituted peptide analogs
|
|
WO2013068874A1
(en)
|
2011-11-11 |
2013-05-16 |
Pfizer Inc. |
Antibody-drug conjugates
|
|
CN104185477B
(zh)
|
2011-11-17 |
2017-05-24 |
辉瑞公司 |
细胞毒性肽及其抗体‑药物缀合物
|
|
SG10201606195UA
(en)
*
|
2012-02-09 |
2016-09-29 |
Var2 Pharmaceuticals Aps |
Targeting of chondroitin sulfate glycans
|
|
CN104640572B
(zh)
|
2012-05-15 |
2018-04-27 |
索伦托医疗有限公司 |
药物偶联物，偶联方法，及其用途
|
|
CN108727466B
(zh)
|
2012-06-07 |
2023-04-28 |
Ambrx公司 |
前列腺特异性膜抗原抗体药物结合物
|
|
KR102190832B1
(ko)
|
2012-06-19 |
2020-12-15 |
암브룩스, 인코포레이티드 |
항cd70 항체 약물 컨쥬게이트
|
|
JP6280546B2
(ja)
|
2012-06-26 |
2018-02-14 |
デル マー ファーマシューティカルズ |
ジアンヒドロガラクチトール、ジアセチルジアンヒドロガラクチトール、ジブロモズルシトール、又はこれらの類似体若しくは誘導体を用いた、遺伝子多型又はａｈｉ１の調節不全若しくは変異を有する患者におけるチロシンキナーゼインヒビター抵抗性悪性腫瘍を処置するための方法
|
|
CA2891280C
(en)
|
2012-11-24 |
2018-03-20 |
Hangzhou Dac Biotech Co., Ltd. |
Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
|
|
US9089614B2
(en)
|
2012-12-21 |
2015-07-28 |
Bioalliance C.V. |
Hydrophilic self-immolative linkers and conjugates thereof
|
|
LT2956173T
(lt)
|
2013-02-14 |
2017-06-26 |
Bristol-Myers Squibb Company |
Tubulizino junginiai, gavimo ir panaudojimo būdai
|
|
HK1220626A1
(zh)
|
2013-03-15 |
2017-05-12 |
The Centre For Drug Research And Development |
具细胞毒性和抗有丝分裂的化合物以及其使用方法
|
|
AU2014337317A1
(en)
|
2013-10-15 |
2016-09-15 |
Sorrento Therapeutics Inc. |
Drug-conjugates with a targeting molecule and two different drugs
|
|
JP6636925B2
(ja)
|
2013-12-17 |
2020-01-29 |
ノバルティス アーゲー |
細胞障害性ペプチドおよびその抱合体
|
|
WO2015095953A1
(en)
|
2013-12-27 |
2015-07-02 |
The Centre For Drug Research And Development |
Sulfonamide-containing linkage systems for drug conjugates
|
|
BR112016015105A8
(pt)
|
2013-12-27 |
2018-04-24 |
Var2 Pharmaceuticals Aps |
conjugados var2csa-droga
|
|
ES2905569T3
(es)
|
2014-09-17 |
2022-04-11 |
Zymeworks Inc |
Compuestos citotóxicos y antimitóticos y métodos para utilizarlos
|
|
US10077287B2
(en)
|
2014-11-10 |
2018-09-18 |
Bristol-Myers Squibb Company |
Tubulysin analogs and methods of making and use
|
|
US10975112B2
(en)
|
2015-06-16 |
2021-04-13 |
Hangzhou Dac Biotech Co., Ltd. |
Linkers for conjugation of cell-binding molecules
|